GLP-1 giant Novo Nordisk partners with OpenAI as pharma industry's AI race accelerates

AI Briefing

• – Novo Nordisk partners with OpenAI to embed AI across its entire drug development pipeline
• – AI will be used in discovery, development, and commercial operations
• – pharma industry's AI race accelerates with major companies like Novo Nordisk joining the trend